Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer

NCT00702572 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Low Enrollment

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Vorinostat, Bevacizumab, Carboplatin, Paclitaxel
DRUG: Vorinostat, Bevacizumab, Carboplatin, Paclitaxel

Sponsor

Milton S. Hershey Medical Center